3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one
C24H31F3N6O2 — CID 161477706
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one
3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one (PubChem CID 161477706) has the molecular formula C24H31F3N6O2 and a molecular weight of 492.55 g/mol. Its IUPAC name is 3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one.
Molecular Properties
| Compound Name | 3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one |
|---|---|
| PubChem CID | 161477706 |
| Molecular Formula | C24H31F3N6O2 |
| Molecular Weight | 492.55 g/mol |
| Exact Mass | 492.25 |
| IUPAC Name | 3-(1H-indol-3-ylmethyl)-1-[3-[4-[2-(trifluoromethoxy)ethyl]piperazin-1-yl]-1H-1,2,4-triazol-5-yl]hexan-1-one |
| SMILES | CCCC(CC(=O)c1nc(N2CCN(CCOC(F)(F)F)CC2)n[nH]1)Cc1c[nH]c2ccccc12 |
| InChI | InChI=1S/C24H31F3N6O2/c1-2-5-17(14-18-16-28-20-7-4-3-6-19(18)20)15-21(34)22-29-23(31-30-22)33-10-8-32(9-11-33)12-13-35-24(25,26)27/h3-4,6-7,16-17,28H,2,5,8-15H2,1H3,(H,29,30,31) |
| InChIKey | YKEGEIFWIAYXJD-UHFFFAOYSA-N |
| XLogP | 4.18 |
| TPSA | 90.14 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.55 |
| LogP ≤ 5 | 4.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161477706 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.